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Background/aim: Broad-spectrum antibiotics have become available for use only with the approval of infectious disease specialists
(IDSs) since 2003 in Turkey. This study aimed to analyze the tendencies of doctors who are not disease specialists (non-IDSs) towards
the restriction of antibiotics.
Materials and methods: A questionnaire form was prepared, which included a total of 22 questions about the impact of antibiotic
restriction (AR) policy, the role of IDSs in the restriction, and the perception of this change in antibiotic consumption. The questionnaire
was completed by each participating physician.
Results: A total of 1906 specialists from 20 cities in Turkey participated in the study. Of those who participated, 1271 (67.5%) had
≤5 years of occupational experience (junior specialists = JSs) and 942 (49.4%) of them were physicians. Specialists having >5 years of
occupational experience in their branch expressed that they followed the antibiotic guidelines more strictly than the JSs (P < 0.05) and
755 of physicians (88%) and 720 of surgeons (84.6%) thought that the AR policy was necessary and useful (P < 0.05).
Conclusion: This study indicated that the AR policy was supported by most of the specialists. Physicians supported this restriction
policy more so than surgeons did.
Key words: Antibiotic policy, antibiotic restriction, antibiotic usage, budget execution instructions, specialist
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1. Introduction
Antibiotics are one of the most valuable, crucial, and
life-saving drugs of the last century. However, antibiotic
resistance emerged right after their usage, and today this
problem threatens the world. In addition, the uncontrolled
and irrational usage of antimicrobials has increased
treatment costs. Moreover, treatment failures may occur
due to infections caused by antibiotic-resistant bacteria
(1,2). Today, the number of newly discovered antibiotics
is quite limited. Thus, new strategies to protect antibiotics
should be considered.
In Turkey, antibiotics constitute 15%–20% of all
prescribed drugs (3). Antibiotics have been number one on
the list of the most commonly used drugs for many years.
The main reasons behind their unnecessary and irrational
usage may be related to a lack of knowledge on antibiotics
due to shortcomings in medical training, pressure and
promotions by the pharmaceutical industry, the absence of
an antibiotic policy, and national antibiotic guidelines (4).
The restriction of certain broad-spectrum antibiotics is an
important strategy for the rational usage of antibiotics. An
antibiotic restriction (AR) policy was shown to enhance
the “rational usage” of antibiotics and to reduce financial
expenditure (5).
Before 2003, every specialist in Turkey was able to
prescribe any antibiotic. However, a law enacted in 2003
stipulated that certain broad-spectrum antibiotics (such
as carbapenems, vancomycin, teicoplanin, linezolid,
daptomycin, piperacillin/tazobactam, etc.) could only
be prescribed with the approval of an infectious disease
specialist (IDS). In brief, if a patient was to be given
a certain broad-spectrum antibiotic, it could only be
prescribed after the approval of an IDS. This AR policy
forms two groups of specialists: IDSs and doctors who
are not infectious disease specialists (non-IDSs). This
creates a negative perception among non-IDSs. While
some non-IDSs consider this approach positive and
useful, the majority of non-IDSs feel that it is useless and
that it hampers patient services, or that it might restrict
specialists’ rights (6).
What kind of an impact did the AR policy have on
non-IDSs? The literature search that we conducted did not
reveal any relevant studies. The aim of this study was to
examine how the AR policy is perceived by non-IDSs and
what kind of behavioral changes it caused. This study is
the first to be carried out in the 8 years since the AR law
passed.
2. Materials and methods
2.1. Study design
This was a multicenter study conducted between August
and December 2011. In sample size calculation, the
approach of achieving a number of participants 50 times
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greater than the number of scale items used in scale studies
was preferred. We planned to conduct the study with 1000
participants from each junior and senior specialist group
because there were 20 items on the scale. For the study
data to be homogeneously distributed over the country, 39
tertiary hospitals from different cities in several regions of
Turkey were determined. The IDSs of those centers were
contacted via email and were invited to participate in the
study. The centers were asked to reply to the invitation
within 1 month. Of these centers, 27 replied affirmatively.
A questionnaire as well as an electronic form prepared
for the centers to note down the results were sent to the
participating centers via email. Each center was asked to
contact 50 surgeons and 50 physicians, conduct a face-toface interview to complete the questionnaire forms, and
record the answers electronically. Finally, the collected
forms were emailed to the coordinating center. Specialists
with ≤5 years of professional experience after the specialty
period were considered “junior specialists” (JSs), and those
with >5 years of professional experience were considered
“senior specialists” (SSs).
2.2. Survey
The first part of the questionnaire included questions
about demographic data, such as the area of specialization,
sex, duration of work in the profession or in the area of
specialization, current place of employment (state hospital,
training hospital, university hospital, private hospital), and
whether the hospital had an IDS or not.
In the second part of the questionnaire, the Scale of
Specialists’ Perception Regarding Antibiotic Restriction
(SSPRAR) was used to examine the changes in AR
brought by the Health Application Communique (HAC)
and the role of the IDS in the restriction and antibiotic
consumption. Two open-ended questions in the scale
evaluated the knowledge of the participants on rational
usage of antibiotics and their behavior when they needed
to prescribe antibiotics requiring IDS approval.
2.3. SSPRAR
This is a scale developed by the research team that included
questions to be answered by non-IDSs. It initially included
20 items but was later reduced to 14 items through
reliability analysis. Respondents were expected to rate each
item using a 5-point Likert type scale (4 = strongly agree, 3
= agree, 2 = disagree, 1 = strongly disagree, 0 = indecisive).
The scale was evaluated by reliability analysis for
internal consistency and the Cronbach alpha coefficient
was calculated (7,8). The scale was evaluated in terms
of additivity with Tukey’s test of additivity, and the
comparisons between groups were made over total scale
scores (8).
Since the 14 items of the scale showed additivity
according to Tukey’s test of additivity (P = 0.148), the
scores of the items constituting the scale were added up.
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Because the scale consisted of 14 items and the highest
score of each item was 4, the maximum score that could
be obtained from the scale was calculated as 56. Since it
would be easier to interpret scores over a total score of
100, the score obtained by each specialist was multiplied
by the ratio of 100/56 and was evaluated over a total score
of 100 to calculate the specialist perception scores (100 =
the score that represents the most positive perception).
2.4. Statistical methods
Since a normal distribution condition was not provided
by the Kolmogorov–Smirnov normality test, the Mann–
Whitney U test was used in the comparisons between
groups in terms of the scale scores used in the study. The
scale scores were shown with median and interquartile
range. A chi-square test was used in the comparisons
between the groups for categorical variables. The odds ratio
was calculated by taking JSs as a reference for the duration
of specialty, and surgeons and physicians in the field of
specialty. Categorical variables were shown as numbers
and percentages. P-values below 0.05 were considered
statistically significant. The calculations were made with
IBM SPSS Statistics 20 (IBM Corp., USA) software.
2.5. Ethical approval
This study was planned as a multicenter prospective
study. The study was approved by the Medical Ethics
Board of Abant İzzet Baysal University (2011/B.30.2.A
BU.0.20.05.04-050.01.0468). All participants were verbally
informed before completing the questionnaires.
3. Results
3.1. Demographical features
A total of 27 centers accepted the invitation, but two of
them did not send any data. Consequently, the study was
completed with the participation of 25 centers and 1906
specialists (581 females, 1325 males) from different parts
of Turkey. Of the participants, 1271 specialists (67.5%)
were JSs, while 611 (32.5%) were SSs. Twenty-four
specialists did not state their duration of experience. Of the
applicants, 942 (49.4%) were physicians and 964 (50.6%)
were surgeons. The average work-related experience
of the specialists in the profession was 10.3 years; 1036
participants (54.4%) were working in university hospitals,
737 (38.5%) in training and research hospitals, 119 (6.2%)
in secondary state hospitals, and 14 (0.7%) in private
hospitals. Of the participants, 1895 (99.4%) were working
in centers with IDSs.
3.2. Results regarding the enforcement of the HAC rules
In total, 77.7% of the participants thought that the HAC
rules were necessary, 69.9% that AR policy had a positive
effect on the budget, and 63.3% that the HAC reduced
the unnecessary use of antibiotics. In addition, 19.7% of
the specialists thought that the choice of antibiotics after

the AR policy was more consistent with the guidelines
compared to the pre-AR period. The great majority
(79.1%) of the participants assumed that IDS consultation
augmented the antibiotic usage quality. A total of 49.2% of
the participants felt that IDS approval results in delayed
initiation of antibiotic treatment. When they were obliged
to prescribe an antibiotic subjected to the restriction,
14.4% of the specialists prescribed an unrestricted
antibiotic, while 83.8% asked for an IDS consultation in
such a situation. Participant answers are summarized in
Figure 1.
SSs thought that their antibiotics knowledge was
better compared to JSs (P < 0.05). Similarly, the number
of surgeons thinking that they had sufficient knowledge
on antibiotics was higher than the physicians (P < 0.05).
The opinion that excessive antibiotic usage increased with
IDS consultation was 33.8% among surgeons and 28.5%
among physicians (P < 0.05). The distribution of the
answers according to professional experience is shown in
Figure 2 and according to branches in Figure 3.
The internal reliability coefficient (Cronbach alpha)
of the SSPRAR was calculated as 0.835. Item–total
correlations were between 0.265 and 0.568. Accordingly,
there was a moderately significant relation between the
items and the total scale. Therefore, the SSPRAR was
considered a reliable scale.
In general, the SSPRAR is a valid, reliable test with
high differential power that can be used in the evaluation
of non-IDSs’ perception regarding AR policy. A significant
difference was found in terms of the SSPRAR between total
scores according to branches and professional experience
(respectively P < 0.001 and P < 0.05) (Table).
4. Discussion
There is a limited number of studies regarding AR rules for
specialists in Turkey. To our knowledge, this study is the
first to explore the impact of nationwide AR through the
participation of different centers. The results of this study
showed that 78% of the non-IDS participants thought
that AR policy was necessary. Most non-IDS participants
also supported such a restriction. The main reason for
this may be the increasing rates of antibiotic resistance in
bacteria. Although non-IDSs think that this restriction is a
limitation of their practice, they are also aware of the risk
presented by antibiotic-resistant bacteria. Therefore, they
are willing to accept the idea that antibiotics, and especially
broad-spectrum antibiotics, should only be prescribed by
specialists in this area (9).
This study, which was conducted years after the
initiation of the implementation of AR policy, showed
that restricted specialists supported the transfer of this
responsibility. Moreover, 69% of the participants thought
that IDS-approved AR had reduced the cost of antibiotic-
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Figure 1. The views of noninfectious disease specialists on antibiotic restriction.

Figure 2. The views of specialists on budget application direction and the mandatory infectious disease and clinical microbiology
specialist approval for certain antibiotics, according to their duration of experience in the area of specialty.
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Figure 3. The distribution of the specialists’ replies to the queries in the survey according to surgical and medical science branches.

Table. The results of the restriction according to the Scale of Physicians’ Perception Regarding Antibiotic Restriction (SSPRAR).

Parameters
Specialty
Sex
Experience

N (%)

SSPRAR total score
Median [IQR]

Min–max

Internal medicine

942 (49.4)

69.64 [53.57–83.93]

20–100

Surgical

964 (50.6)

66.07 [50.00–80.36]

00–100

Female

581 (30.5)

67.86 [50.00–83.93]

5.36–100

Male

1325 (69.5)

67.86 [51.79–82.14]

20–100

Junior physicians

1271 (67.5)

66.07 [50.00–82.14]

0–100

Senior physicians

611 (32.5)

69.64 [53.57–83.93]

0–100

related therapy and 63% thought that this approach
reduced antibiotic consumption. All these data also
confirm that non-IDSs support this policy.
According to the SSPRAR used in this study, SSs had
a more favorable attitude towards the AR policy, whereas
the perception that the restriction was unnecessary was
more common among JSs, which may be attributed to
their unawareness of the resistance threat. We feel that
they would be more cooperative and would not see the
restriction as a limitation of their antibiotic prescription
freedom if they were better informed about and aware of
this threat (10).
According to the SSPRAR, the negative perception
of the AR policy among surgeons was much higher than
among physicians. Furthermore, the need for current

P-value
<0.001
0.928
<0.05

guidelines for prescription of antibiotics was significantly
higher among physicians than among surgeons (85% versus
78%, P < 0.05). This may be attributed to the surgeons’
antibiotic-prescribing habits (11). In addition, SSs refer
to guidelines more often while prescribing antibiotics,
whereas JSs need less reference to guidelines (85.3% versus
79.5%, P < 0.05). However, SSs think that their knowledge
on antibiotics is sufficient, while JSs find it insufficient.
The reason why experienced specialists consider their
knowledge on antibiotics sufficient might be due to the fact
that they refer to guidelines more often. In addition, the
fact that JSs refer to the guidelines less frequently might
be related to the fact that they have developed the habit
of transferring the decision of prescribing broad-spectrum
antibiotics to IDS consultations. Another reason might

137

KARABAY et al. / Turk J Med Sci
be the idea that SSs are familiar with the effects and side
effects of antibiotics, since they were freely prescribing
antibiotics for years. As far as prescribing antibiotics after
IDS consultations is concerned, JSs might not be interested
in learning more about the subject (6).
The opinion that IDS consultations increase the
prescription of unnecessary and broad-spectrum
antibiotics was held more often by surgeons than
physicians (33.8% versus 28.3%, P < 0.05). This might be
related to the lack of communication between IDSs and
surgeons, the surgeons’ antibiotic-prescribing habits, and
the surgical infections associated with this application. In
addition, while the majority of bacteria were sensitive to
many antibiotics in the early 2000s, antibiotic resistance
rates of bacteria known to cause hospital infections are
very high nowadays (12).
In total, 49.2% of the participants thought that the AR
policy requiring IDS approval delayed the initiation of
antibiotic treatment. Moreover, there was no difference
between surgeons and physicians or between JSs and SSs
in this respect. Consultations in hospitals require several
procedures, and sometimes it may take 1–6 h to conclude
a consultation in busy hospitals (6). In serious conditions
such as sepsis, the delayed initiation of antibiotic treatment

due to prolonged consultation times may risk the life
of the patient (13). Therefore, IDSs should attend the
consultations as quickly as possible, especially in cases of
patients with infectious emergencies (14).
Our study has some limitations. First, we asked
clinicians who assumed that the AR policy is rational and
reasonable and who had good relations with the IDS to
participate in the study, leading to a bias in the selection
of study participants. Second, the number of specialists
working in secondary state hospitals and in private
hospitals who participated in our survey was smaller
than the number of the participants who were working
in tertiary-care hospitals. Thus, we might not have been
able to accurately compare the views of specialists in
secondary- and tertiary-care hospitals on AR policy.
In conclusion, the restricted usage of antibiotics is
favored by four-fifths of non-IDSs who agree that this
approach reduces costs. Physicians support this restriction
more so than surgeons. However, it is important to note
that the AR policy requiring the IDSs’ approval is perceived
to delay the initiation of antibiotic treatment. Hence, there
is a need for new policies that will increase the cooperation
between IDSs and other branch specialists and that will
encourage the rational usage of antibiotics.
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